Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Carcinogenesis
|
September 1, 1996
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual
J T Lear, A H Heagerty, A Smith, et al.
The British Journal of Dermatology
|
March 29, 2000
Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas
A H Hajeer, J T Lear, W E Ollier, et al.
Pharmacogenetics
|
September 2, 1999
Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma
R C Strange, T Ellison, F Ichii-Jones, et al.
Clinical and Experimental Dermatology
|
December 3, 2016
Treatment of severe, chronic hand eczema: results from a UK-wide survey
I L Smith, S Brown, J Nixon, et al.
Cancer Research
|
May 1, 1996
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma
L Yengi, A Inskip, J Gilford, et al.
The British Journal of Dermatology
|
May 22, 2018
Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment
D Kopasker, A Kwiatkowski, R N Matin, et al.
The Journal of Investigative Dermatology
|
August 12, 1998
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene
F Ichii-Jones, J T Lear, A H Heagerty, et al.
The British Journal of Dermatology
|
September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study
R Dummer, A Guminksi, R Gutzmer, et al.
The British Journal of Dermatology
|
March 3, 2020
Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK
C E Gollins, A Shah, K Sinha, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
J T Lear, M R Migden, K D Lewis, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Carcinogenesis
|
September 1, 1996
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual
J T Lear, A H Heagerty, A Smith, et al.
The British Journal of Dermatology
|
March 29, 2000
Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas
A H Hajeer, J T Lear, W E Ollier, et al.
Pharmacogenetics
|
September 2, 1999
Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma
R C Strange, T Ellison, F Ichii-Jones, et al.
Clinical and Experimental Dermatology
|
December 3, 2016
Treatment of severe, chronic hand eczema: results from a UK-wide survey
I L Smith, S Brown, J Nixon, et al.
Cancer Research
|
May 1, 1996
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma
L Yengi, A Inskip, J Gilford, et al.
The British Journal of Dermatology
|
May 22, 2018
Patient preferences for topical treatment of actinic keratoses: a discrete-choice experiment
D Kopasker, A Kwiatkowski, R N Matin, et al.
The Journal of Investigative Dermatology
|
August 12, 1998
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene
F Ichii-Jones, J T Lear, A H Heagerty, et al.
The British Journal of Dermatology
|
September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study
R Dummer, A Guminksi, R Gutzmer, et al.
The British Journal of Dermatology
|
March 3, 2020
Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK
C E Gollins, A Shah, K Sinha, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
J T Lear, M R Migden, K D Lewis, et al.
Page
of 12